Because for a proper rerate the market needs official confirmation of clinical validation, preferably with official sensitivity etc figures Nothing to do with competing tests
Sandy, you been on the bottle ? You're normally so level headed on here Tell our friend how many shares have to be issued to pay off Atlas if the SP reaches say 00.53 ?
" The other thing to consider is the US is currently recording daily positive cv tests records of over 70,000 cases a day. Who the hell knows how many untested cases they have.
we know that even with a complete and total lockdown (which won’t happen) that infection number won’t start dropping for at least 2 weeks.
so within the next fortnight they will be adding at least a million more positive tested cases to their total... and that figure won’t stop there. It will keep growing and increasing exponentially for months to come unless they take drastic measures like a total countrywide lockdown. Again which just won’t happen.
So given that the US is currently doubling its case load total every 10 days.
If that continues unabated they have 4.5 million infections by the end of this month...
9 million by middle of August, 18 million by the end of August... etc etc
the US current positive test to death rate stands at around 4% (3.5 million positive tests to 140k deaths) this is very rough and we know that deaths lag infection by around 14 days...and we also know that in the early days there was a total lack of testing... (I acknowledge that there is huge amount of Inaccuracy in these figures and data and I am not in any way stating they are correct because we just don’t have the data to know) but even on these rough of roughest calculations the US could be looking at somewhere between 500,000 to 1 million dead by mid September. "
Absolutely not. All information will be in the public domain, and accordingly there will be no false market Authorities do not suspend a share so that punters can 'absorb' information. Suspension is a very serious business